Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders??? Equity (Unaudited)

v3.21.2
Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional paid-in capital
Accumulated deficit
Total
Balance at Dec. 31, 2019 $ 3 $ 102,789 $ (84,464) $ 18,328
Balance (in Shares) at Dec. 31, 2019 28,811,087      
Issuance of common shares upon vesting of restricted stock units
Issuance of common shares upon vesting of restricted stock units (in Shares) 15,070      
Share based compensation 804 804
Net loss (6,511) (6,511)
Balance at Mar. 31, 2020 $ 3 103,593 (90,975) 12,621
Balance (in Shares) at Mar. 31, 2020 28,826,157      
Issuance of common shares upon vesting of restricted stock units
Issuance of common shares upon vesting of restricted stock units (in Shares) 30,916      
Share based compensation 678 678
Net loss (4,410) (4,410)
Balance at Jun. 30, 2020 $ 3 104,271 (95,385) 8,889
Balance (in Shares) at Jun. 30, 2020 28,857,073      
Issuance of common shares upon vesting of restricted stock units
Issuance of common shares upon vesting of restricted stock units (in Shares) 30,916      
Issuance of common shares upon offering, net of financing fees of $830   9,164   9,164
Issuance of common shares upon offering, net of financing fees of $830 (in Shares) 3,200,000      
Issuance of common stock upon exercise of warrants   58   58
Issuance of common stock upon exercise of warrants (in Shares) 50,000      
Issuance of common stock for board of directors’ compensation   55   55
Issuance of common stock for board of directors’ compensation (in Shares) 44,600      
Share based compensation 771 771
Net loss (3,938) (3,938)
Balance at Sep. 30, 2020 $ 3 114,319 (99,323) 14,999
Balance (in Shares) at Sep. 30, 2020 32,182,589      
Balance at Dec. 31, 2020 $ 3 115,008 (103,721) 11,290 [1]
Balance (in Shares) at Dec. 31, 2020 32,272,309      
Issuance of common shares upon vesting of restricted stock units
Issuance of common shares upon vesting of restricted stock units (in Shares) 65,915      
Issuance of common shares upon exercise of warrants, net of financing costs of $366 $ 2 11,591 11,593
Issuance of common shares upon exercise of warrants, net of financing costs of $366 (in Shares) 14,267,250      
Issuance of common stock for board of directors’ compensation 272 272
Issuance of common stock for board of directors’ compensation (in Shares) 173,554      
Share based compensation 919 919
Net loss (4,649) (4,649)
Balance at Mar. 31, 2021 $ 5 127,790 (108,370) 19,425
Balance (in Shares) at Mar. 31, 2021 46,779,028      
Issuance of common shares, net of issuance costs of $74 1,826 1,826
Issuance of common shares, net of issuance costs of $74 (in Shares) 1,340,870      
Issuance of common stock to consultants 53 53
Issuance of common stock to consultants (in Shares) 50,000      
Issuance of common shares upon vesting of restricted stock units
Issuance of common shares upon vesting of restricted stock units (in Shares) 53,081      
Issuance of common stock for board of directors’ compensation 19 19
Issuance of common stock for board of directors’ compensation (in Shares) 18,209      
Share based compensation 1,010 1,010
Net loss (4,742) (4,742)
Balance at Jun. 30, 2021 $ 5 130,698 (113,112) 17,591
Balance (in Shares) at Jun. 30, 2021 48,241,188      
Issuance of warrants associated with convertible note and long-term debt   165   165
Share based compensation 848 848
Net loss (4,824) (4,824)
Balance at Sep. 30, 2021 $ 5 $ 131,711 $ (117,936) $ 13,780
Balance (in Shares) at Sep. 30, 2021 48,241,188      
[1] Derived from audited consolidated financial statements